ACTIVE

Dr. Olivier Boey - inwendige ziekten-nefrologie

Financial year 2025 · Closed on 31/12/2025

Net result280,8 k €+1,7 %over 1 year

Gross margin477,9 k €+15,4 %over 1 year

Equity1,9 M €-9,6 %over 1 year

Identity

Source · BCE/KBO

Dr. Olivier Boey - inwendige ziekten-nefrologie is a Private limited company incorporated in 2009. Its registered office is in Gent.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0811.113.208
Incorporation: 10/04/2009
Legal form: Private limited company
Registered office: Maaltemeers 74
9052 Gent · FlandreSee on map
Contributed capital: 18 600,00 €
Latest accounts: 31/12/2025

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 19 filings

Trend over 17 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	477,9 k €	+15.4%	414,1 k €	+12.8%	367,1 k €	-27.6%	507,4 k €	-15.0%	596,9 k €
EBITDA	474,1 k €	+15.6%	410,1 k €	+12.7%	363,9 k €	-28.0%	505,3 k €	-15.0%	594,4 k €
Operating result	435,8 k €	+13.7%	383,1 k €	+9.0%	351,5 k €	-28.9%	494,4 k €	-15.3%	583,8 k €
Net result	280,8 k €	+1.7%	276 k €	-0.4%	277,1 k €	+13.5%	244,1 k €	-57.8%	578,9 k €
Balance sheet
Equity	1,9 M €	-9.6%	2,2 M €	+14.7%	1,9 M €	+15.1%	1,6 M €	+8.5%	1,5 M €
Total assets	2,1 M €	-9.4%	2,3 M €	+15.9%	2 M €	-0.1%	2 M €	-30.6%	2,8 M €
Cash	29,2 k €	-76.2%	122,7 k €	-20.8%	154,9 k €	+204%	50,9 k €	-84.8%	335,4 k €
Debts	124,5 k €	-6.2%	132,7 k €	+40.3%	94,6 k €	-72.3%	341,8 k €	-74.5%	1,3 M €

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 2 ended

Active mandates

Director	Mandates in this company	Period
Olivier Boey	Directorsince 10/04/2019Manager02/04/2009 → 02/04/2019ended

Ended mandates

Director	Mandates in this company	Period
Olivier Dr Boey	Directorsince 12/06/2019
Olivier DR. Boey	Directorsince 12/06/2019

Other companies at this address

Maaltemeers 74 9052 Gent

Company	CBE no.
Dempre● Active	0766.764.115

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Abridged model	Micro model	Micro model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	31/08/2026	25/09/2025	30/08/2024	25/08/2023	28/06/2022	31/08/2021
General meeting	30/06/2026	30/06/2025	30/06/2024	14/06/2023	08/06/2022	09/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 19 filings

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	30/06/2026	31/08/2026	Dutch	PDF
Micro model	31/12/2024	30/06/2025	25/09/2025	Dutch	PDF
Abridged model	31/12/2023	30/06/2024	30/08/2024	Dutch	PDF
Micro model	31/12/2022	14/06/2023	25/08/2023	Dutch	PDF
Micro model	31/12/2021	08/06/2022	28/06/2022	Dutch	PDF
Abridged model	31/12/2020	09/06/2021	31/08/2021	Dutch	PDF
Abridged model	31/12/2019	10/06/2020	21/08/2020	Dutch	PDF
Abridged model	31/12/2018	12/06/2019	31/08/2019	Dutch	PDF
Abridged model	31/12/2017	13/06/2018	14/08/2018	Dutch	PDF
Abridged model	31/12/2016	14/06/2017	02/08/2017	Dutch	PDF
Abridged model	31/12/2015	08/06/2016	28/07/2016	Dutch	PDF
Abridged model	31/12/2014	10/06/2015	12/08/2015	Dutch	PDF
Abridged model	31/12/2013	11/06/2014	29/08/2014	Dutch	PDF
Abridged modelCorrection	31/12/2012	12/06/2013	11/10/2013	Dutch	PDF
Abridged model	31/12/2012	12/06/2013	28/08/2013	Dutch	PDF
Abridged model	31/12/2011	29/08/2012	25/09/2012	Dutch	PDF
Abridged model	31/12/2010	08/06/2011	31/08/2011	Dutch	PDF
Abridged modelCorrection	31/12/2009	09/06/2010	30/11/2010	Dutch	PDF
Abridged model	31/12/2009	09/06/2010	23/08/2010	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 2 ended

Active mandates

Director	Mandates in this company	Period
Olivier Boey	Directorsince 10/04/2019Manager02/04/2009 → 02/04/2019ended

Ended mandates

Director	Mandates in this company	Period
Olivier Dr Boey	Directorsince 12/06/2019
Olivier DR. Boey	Directorsince 12/06/2019

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Other11/12/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM
PDF
Mandates28/01/2020
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares12/07/2018
KAPITAAL - AANDELEN
PDF
Capital / shares26/02/2014
KAPITAAL - AANDELEN
PDF
Other21/04/2009
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings17 filings

Mandates

Olivier Boey

Olivier Dr Boey

Olivier DR. Boey

200920102011201220132014201520162017201820192020202120222023202420252026

Dr. Olivier Boey - inwendige ziekten-nefrologieDr. Olivier Boey Inwendige ziekten-Nefrologie BVBA

Maaltemeers 74, 9052 Zwijnaarde

DirectorManager

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Maaltemeers 74, 9052 ZwijnaardeCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00462451

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
Dr. Olivier Boey - inwendige ziekten-nefrologieCurrent	accounts 2024 → 2025	Accounts 2025 · 2026-00462451
BOEY OLIVIER - INWENDIGE ZIEKTEN-NEFROLOGIE DR.	accounts 2023	Accounts 2023 · 2024-00447728
Dr. Olivier Boey Inwendige ziekten-Nefrologie BVBA	accounts 2021 → 2022	Accounts 2022 · 2023-00376259

Events

2025
Annual accounts 2025280,8 k €↑
2024
Annual accounts 2024276 k €↓
2024
Name changeDr. Olivier Boey - inwendige ziekten-nefrologie
2023
Annual accounts 2023277,1 k €↑
2023
Name changeBOEY OLIVIER - INWENDIGE ZIEKTEN-NEFROLOGIE DR.
2022
Annual accounts 2022244,1 k €↓
2021
Annual accounts 2021578,9 k €↑
2020
Annual accounts 2020244,1 k €↓
2019
Annual accounts 2019309,1 k €↑
2018
Annual accounts 2018178,7 k €↑
2017
Annual accounts 201737,2 k €↑
2016
Annual accounts 2016-43,8 k €↓
2015
Annual accounts 2015366,9 k €↓
2014
Annual accounts 2014372,1 k €↓
2013
Annual accounts 2013525,1 k €↑
2012
Annual accounts 2012371,7 k €↑
2011
Annual accounts 2011272,1 k €↑
2010
Annual accounts 2010184,9 k €↑
2009
Annual accounts 2009103,9 k €
10/04/2009
IncorporationPrivate limited company

Dr. Olivier Boey - inwendige ziekten-nefrologie

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events